Human Mast Cells Stimulate Activated T Cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1196/annals.1418.029PMID 19076366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Luteolin inhibits myelin basic protein‐induced human mast cell activation and mast cell‐dependent stimulation of Jurkat T cells

  2008cited by this paper
• IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells

  2007cited by this paper
• Corticotropin-releasing hormone and the blood-brain-barrier.

  2007cited by this paper
• Regulation of mast cell development by inflammatory factors.

  2007cited by this paper
• IL-17 family cytokines and the expanding diversity of effector T cell lineages.

  2007cited by this paper
• Regulation of IL‐1‐induced selective IL‐6 release from human mast cells and inhibition by quercetin

  2006cited by this paper
• Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE.

  2006cited by this paper
• Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway

  2006cited by this paper
• The Critical Role of Mast Cells in Allergy and Inflammation

  2006cited by this paper
• Th17: an effector CD4 T cell lineage with regulatory T cell ties.

  2006cited by this paper
• Towards individualised multiple-sclerosis therapy

  2005cited by this paper
• Human mast cells release Interleukin‐8 and induce neutrophil chemotaxis on contact with activated T cells

  2005cited by this paper
• Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

  2005cited by this paper
• Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor1

  2005cited by this paper
• Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis

  2005cited by this paper
• Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells

  2005cited by this paper
• Towards individualised multiple-sclerosis therapy.

  2005cited by this paper
• Mast cells in the development of adaptive immune responses

  2005cited by this paper
• Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

  2005cited by this paper
• Mast cells in innate immunity.

  2004cited by this paper
• Critical role of mast cells in inflammatory diseases and the effect of acute stress.

  2004cited by this paper
• Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune Encephalomyelitis1

  2004cited by this paper
• IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice.

  2004cited by this paper
• Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis

  2004cited by this paper
• Lysophosphatidic acid accelerates the development of human mast cells.

  2004cited by this paper
• The CD 4 – Th 1 model for multiple sclerosis : a crucial reappraisal

  2004cited by this paper
• The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells.

  2004cited by this paper
• The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal

  2004cited by this paper
• Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro

  2004cited by this paper
• Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells.

  2004cited by this paper
• Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study.

  2003cited by this paper
• Blood-brain barrier disruption in multiple sclerosis

  2003cited by this paper
• Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.

  2003cited by this paper
• Stem cell factor: a hemopoietic cytokine with important targets in asthma.

  2003cited by this paper
• Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination

  2003cited by this paper
• Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis.

  2003cited by this paper
• Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?

  2003cited by this paper
• IL-9 Enhances the Growth of Human Mast Cell Progenitors Under Stimulation with Stem Cell Factor1

  2003cited by this paper
• Mast cells to the defense

  2003cited by this paper
• Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases.

  2003cited by this paper
• Mast cell–dependent migration of effector CD8+ T cells through production of leukotriene B4

  2003cited by this paper
• Mechanisms underlying mast cell influence on EAE disease course.

  2002cited by this paper
• Mast cells: new targets for multiple sclerosis therapy?

  2002cited by this paper
• Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

  2002cited by this paper
• Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress

  2002cited by this paper
• Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors

  2001cited by this paper
• Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.

  2001cited by this paper
• Role of Free Radicals in the Neurodegenerative Diseases

  2001cited by this paper
• Mast cells and multiple sclerosis: a quantitative analysis

  2001cited by this paper
• Effects of luteolin, quercetin and baicalein on immunoglobulin E‐mediated mediator release from human cultured mast cells

  2000cited by this paper
• The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

  2000cited by this paper
• Effects of Luteolin and Other Flavonoids on IgE-Mediated Allergic Reactions

  2000cited by this paper
• Mast cells in innate immunity

  2000cited by this paper
• Increased T‐lymphocyte interleukin‐6 binding in patients with multiple sclerosis

  2000cited by this paper
• [The pathogenic role of inflammation in multiple sclerosis].

  2000cited by this paper
• Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis.

  2000cited by this paper
• Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P.

  2000cited by this paper
• Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34[+] cord blood cells

  1999cited by this paper
• Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells.

  1999cited by this paper
• The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

  1999cited by this paper
• Cord blood‐derived human cultured mast cells produce transforming growth factor β1

  1999cited by this paper
• Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation.

  1998cited by this paper
• Effect of plant flavonoids on immune and inflammatory cell function.

  1998cited by this paper
• Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

  1998cited by this paper
• A CD4+ proliferation of large granular lymphocytes expresses the protease activated receptor‐1

  1998cited by this paper
• Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2*

  1997cited by this paper
• The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells.

  1997cited by this paper
• Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis

  1996cited by this paper
• The mast cells of the multiple sclerosis brain.

  1996cited by this paper
• Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients

  1995cited by this paper
• Blood‐brain barrier disruption on contrast‐enhanced MRI in patients with mild relapsing‐remitting multiple sclerosis

  1995cited by this paper
• Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats.

  1995cited by this paper
• Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination.

  1993cited by this paper
• Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

  1993cited by this paper
• Mast cell proteases liberate stable encephalitogenic fragments from intact myelin.

  1991cited by this paper
• New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity.

  1990cited by this paper
• The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation.

  1988cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Neuropeptide regulation of the expression of immediate hypersensitivity.

  1985cited by this paper
• Mast cells and the actions of flavonoids.

  1984cited by this paper
• Flavonols and flavones in food plants: a review†

  1976cited by this paper

• Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut–Brain Axis and Helicobacter pylori Infection

  2024cites this paper
• Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy

  2024cites this paper
• The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis

  2024cites this paper
• Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?

  2022cites this paper
• Mast cell tissue heterogeneity and specificity of immune cell recruitment

  2022cites this paper
• The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation.

  2021cites this paper
• Role of Mast Cells in Shaping the Tumor Microenvironment

  2019cites this paper
• Mast Cell Biology at Molecular Level: a Comprehensive Review

  2019cites this paper
• Innate Immunity Cells and the Neurovascular Unit

  2018cites this paper
• An Inflammation-Centric View of Neurological Disease: Beyond the Neuron

  2018cites this paper
• Emerging drugs for primary progressive multiple sclerosis

  2018cites this paper
• Mast cells participate in chronic low‐grade inflammation within adipose tissue

  2018cites this paper
• Trials of Novel Therapies Specifically for Progressive MS

  2018cites this paper
• Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons

  2017cites this paper
• Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis

  2017cites this paper
• Upcoming therapeutic options for progressive multiple sclerosis

  2017cites this paper
• The role of mast cells in oral squamous cell carcinoma

  2017cites this paper
• The effects of Omega-3, Omega-6 Polyunsaturated Fatty Acids (PUFAs) and Vitamin E on patients with the remitting-relapsing (RR) form of Multiple Sclerosis (MS) in Cyprus

  2016cites this paper
• Identification of Bromodomain-Containing Protein 4 (BRD4) as a Novel Marker and Epigenetic Target in Systemic Mastocytosis and Mast Cell Leukemia

  2016influential citation
• A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives

  2016cites this paper
• Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

  2016cites this paper
• The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder

  2016influential citation
• Disease-modifying therapy for multiple sclerosis

  2015cites this paper
• Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

  2015cites this paper
• Role of Nutritional Factors in Multiple Sclerosis

  2014cites this paper
• The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

  2014cites this paper
• Effect of stress on brain inflammation and multiple sclerosis.

  2013cites this paper
• Anti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cells.

  2013cites this paper
• [Emerging therapies for multiple sclerosis].

  2013cites this paper
• The induction and effects of Substance P and its receptor in human immune cells and neurons : potential relevance in multiple sclerosis

  2012cites this paper
• Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.

  2012cites this paper
• A relation between TGF-β and mast cell tryptase in experimental emphysema models.

  2012cites this paper
• Histamine: an undercover agent in multiple rare diseases?

  2012cites this paper
• Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

  2012cites this paper
• Mast cells: an expanding pathophysiological role from allergy to other disorders

  2012cites this paper
• Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients.

  2011cites this paper
• The significant role of mast cells in cancer

  2011cites this paper
• Mast cells and COPD.

  2011cites this paper
• The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism

  2011influential citation
• IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates

  2011cites this paper
• Stress and Multiple Sclerosis: What’s New?

  2011cites this paper
• Signaling Pathways in the Activation of Mast Cells Cocultured with Astrocytes and Colocalization of Both Cells in Experimental Allergic Encephalomyelitis

  2010influential citation
• Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.

  2010cites this paper
• Allergic Encephalomyelitis Colocalization of Both Cells in Experimental Cells Cocultured with Astrocytes and Signaling Pathways in the Activation of Mast

  2010influential citation
• Role of the innate immune system in the pathogenesis of multiple sclerosis.

  2010cites this paper
• Natural products AKTing on signal transduction pathways-molecules and methods

  2009cites this paper
• Immunomodulatory and anti-inflammatory effects of chondroitin sulphate

  2009cites this paper
• Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β

  2009influential citation
• [Th17 cells in the pathogenesis of multiple sclerosis].

  2009cites this paper